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Abstract
Background: In our previous study concerning the genetic relationship among H10 avian influenza viruses with
different pathogenicity in mink (Mustela vison), we found that these differences were related to amino acid
variations in the NS1 protein. In this study, we extend our previous work to further investigate the effect of the
NS1 from different gene pools on type I IFN promoter activity, the production of IFN-b, as well as the expression of
the IFN-b mRNA in response to poly I:C.
Results: Using a model system, we first demonstrated that NS1 from A/mink/Sweden/84 (H10N4) (allele A) could
suppress an interferon-stimulated response element (ISRE) reporter system to about 85%. The other NS1 (allele B),
from A/chicken/Germany/N/49 (H10N7), was also able to suppress the reporter system, but only to about 20%. The
differences in the abilities of the two NS1s from different alleles to suppress the ISRE reporter system were clearly
reflected by the protein and mRNA expressions of IFN-b as shown by ELISA and RT-PCR assays.
Conclusions: These studies reveal that different non-structural protein 1 (NS1) of influenza viruses, one from allele
A and another from allele B, show different abilities to suppress the type I interferon b expression. It has been
hypothesised that some of the differences in the different abilities of the alleles to suppress ISRE were because of
the interactions and inhibitions at later stages from the IFN receptor, such as the JAK/STAT pathway. This might
reflect the additional effects of the immune evasion potential of different NS1s.
Background
Type I interferons (IFNs) play an essential role in both
the innate immune response and the induction of adap-
tive immunity against viral infections. Viral infections
trigger the production of type I IFNs (IFN-a/b)[ 1 , 2 ] ,
which leads to the activation of several hundred IFN-sti-
mulated genes (ISGs). These genes encode a variety of
antiviral proteins and cytokines, leading to the protec-
tion of the host from further viral infections [3,4].
The main viral sensors in most mammalian nucleated
cells are RNA helicases, retinoic acid-inducible gene I
(RIG-I) and melanoma differentiation-associated protein
5 (MDA-5), which recognises viral single-stranded RNA
(ssRNA) and double-stranded RNA (dsRNA) [1,5-9].
Many cells also recognise viral dsRNA through Toll-like
receptor 3 (TLR3) [1,10]. The binding of virus-derived
nucleic acids to RIG-I, MDA-5 or TLR3 results in a
coordinated activation of the transcription factors
nuclear factor kappa B (NF-B) and interferon regula-
tory factor 3 (IRF-3), leading to IFN-b production in
mammals [6,7,10].
Although a variety of cellular signalling has been
evolved in host cells for detecting and responding to
viral infection, most viruses possess mechanisms to
evade these host immune responses to various degrees
[7,11]. For example, many viruses have developed a mul-
titude of mechanisms to evade the IFN response by
either blocking IFN synthesis or interfering with the
functions of IFN [12].
In the case of influenza A viruses, the non-structural
gene (NS) has been shown to be responsible for viral
anti-IFN activities [13-16]. The NS gene of influenza A
viruses encodes for two proteins [17]. The first is
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encodes a protein of 26 kDa known as non-structural
protein 1 (NS1). The second is a 14 kDa nuclear export
p r o t e i n( N E P ,f o r m e r l yc a l l e dN S 2 )t r a n s l a t e df r o m
spliced mRNA [18].
The NS1 protein antagonises both the induction of
IFN-b [19,20] and the activity of several IFN-induced
proteins with antiviral activities such as protein kinase R
(PKR) and 2’-5’oligoadenylate synthetase (OAS) [21-23].
The NS gene can be classified into separate gene
pools, termed alleles A and B [24,25]. Between allele A
and B, 63-68% nucleotide identity and 66-70% amino
acid identity was found between the NS1 proteins. The
NS allele A is more common and is the only subtype
found in mammalian-adapted isolates. In a comparison
between amino acid sequence of avian allele A and B
viruses with an amino acid sequence of human viruses,
six amino acid motifs, or signatures, were found
between human and avian allele A viruses, and 35 signa-
tures between human and allele B viruses, indicating
that allele B viruses are more distinct from mammalian
origin viruses [26]. This suggests that the adaptation of
NS1 plays an important role in the pathogenicity of
avian influenza viruses in mammalian species.
In our previous study concerning the genetic relation-
ship among H10 avian influenza viruses with different
pathogenicity in mink (Mustela vison), we found that
these differences were related to amino acid variations
in the NS1 protein. We demonstrated that in a model
system using polyinosinic-polycytidylic acid (poly I:C)-
stimulated mink lung cells, the NS1 protein of influenza
A virus isolated from mink (A/mink/Sweden/84
(H10N4)) down regulated type I IFN promoter activity
to a greater extent than the NS1 protein of prototype
H10 virus (known as virus/N (A/chicken/Germany/N/49
(H10N7)) [27].
In this study, we extend our previous work to further
investigate the effect of the NS1 from different gene
pools on type I IFN promoter activity, the production of
IFN-b, as well as the expression of the IFN-b mRNA in
response to poly I:C.
Results
Activation of IFN-b promoter
First, we studied the ability of NS1 from “mink/84” and
“chicken/49” to inhibit the induction of transcription of
the IFN-b gene, using the model system ISRE-Luciferase
and Poly I:C stimulation. This reporter system relies on
expression of IFN and the subsequent signalling from
the IFN-a/b receptor leading to expression from the
ISRE reporter gene (luciferase). Although both NS1
from “mink/84” and “chicken/49” showed a significant
suppressive effect on the luciferase activity, it was con-
siderably stronger in cells transfected with “mink/84”
with an average of 6.8 fold decrease (85.3%) in A549
cells (Figure 1A), compared with “chicken/49”,t h a to n
average produced a 20.8% decrease in A549 cells.
Expression of NS1 proteins in A549 cells
To find out whether the difference in inhibition of IFN-
b promoter is duo to difference in- or insufficient
expression of the NS1 proteins in A549 cells, the level
of expressed NS1 proteins was confirmed by western
b l o ta n a l y s i s .T h ec e l l sw e r el y s e da t0 ,2 ,4 ,8 ,1 6a n d
24 hours post transfection and western blotting was per-
formed. The NS1 proteins from both constructs were
expressed in high quantity and the level of allele A NS1
was comparable to NS1 protein of allele B (Figure 1B).
The western blotting showed that the expressed protein
from both “mink/84” and “chicken/49” was homoge-
nously accumulated in A549 cells and there was no
notable difference between alleles in term of NS1 pro-
duction (Figure 1B). Thus, the results indicated that the
difference in IFN-b induction in the presence of allele B
Figure 1 Prevention of poly (I:C) induced activation of an IFN-b
promoter by the NS1 protein in A549 cells. (A) Forty-eight hours
after transfection, the cells were harvested and assayed for luciferase
activity. Average relative luciferase activities are reported. Data are
expressed as the mean ± S.E. for the three independent
experiments performed in duplicate. (B)Western blotting was
performed to compare level of expression of the two NS1
constructs. Expression of the NS1 proteins in A549 cells transfected
with the NS1 constructs; pNS-chicken/49 and pNS-mink/84, was
confirmed at 0, 2, 4, 8, 16 and 24 hours post transfection.
Zohari et al. Virology Journal 2010, 7:376
http://www.virologyj.com/content/7/1/376
Page 2 of 8NS1 protein was not due to difference in allele B NS1
protein expression and accumulation in the cells.
At this point it was not clear if this result corre-
sponded to differences in the ability to downregulate
IFN production, or that the signalling pathway leading
to ISRE transcription is influenced, or both. To sort out
this, IFN protein production was measured by an ELISA.
IFN-b production
The IFN-b protein was detected in the cell medium of
the control cells after a lag of 2 to 4 hours after poly I:C
stimulation, followed by the linear accumulation of IFN-
b in the cell culture supernatant. The peak yields for
control cells were reached about 16 to 24 hours post-
stimulation (Figure 2A). Although low levels of IFN-b
were secreted by cells transfected with different NS1s,
significant differences were observed between these
NS1s. Those cells expressing the NS1 protein of “mink/
84” virus were weak producers of IFN-b, with at least 10
times lower levels of IFN-b secreted in the cell culture
supernatant than the control cells. In these cells IFN-b
secreted to the supernatant reached the maximum yield
8 hours post-stimulation and declined rapidly to a low
level for the rest of the experiment. By contrast, cells
expressing the NS1 protein of “chicken/49” were better
producers of IFN-b with the profile lower but similar to
that observed with the control cells (Figure 2A). This
indicates that NS1, in this system, suppresses IFN pro-
tein production rather than the signalling from the IFN
receptor.
Expression of IFN-b in response to poly I:C
To determine whether the reduction of IFN-b produc-
tion was caused by the suppression of the expression of
the IFN-b gene, we compared gene expression kinetics
in A549 cells stimulated with poly I:C in the presence
or absence of different NS1 proteins.
In the control cells, IFN-b mRNA was detected in
increased amounts during the entire period of the
experiment (Figure 2B). The same profile was observed
in the cells expressing the NS gene of “chicken/49 “
(Figure 2C). Transcript levels in the control cells were
significantly increased 2 to 4 hours post-stimulation,
reaching a plateau at the end of the experiment. Four
hours after stimulation, the NS1 protein of the “mink/
84” effectively suppressed IFN-b gene transcription in
A549 cells (Figure 2D). The activation of the IFN-b
gene expression in cells transfected with plasmids carry-
ing the NS gene of “chicken/49” resulted in increased
levels of IFN-b mRNA showing the same trend similar
to the control cells.
The RT-PCR analysis of the INF-b mRNA presented
in the stimulated A549 cells expressing NS1 of “mink/
84” or “chicken/49” confirmed that the NS1 protein of
“mink/84” effectively suppressed IFN-b gene transcrip-
tion in A549 cells, indicating that the main target of the
“mink/84” NS1 is the induction of IFN.
Discussion
One of the main strategies of the influenza A viruses to
a v o i dh o s ti m m u n er e s p o n s e si st oi n h i b i tI F N - a/b
expression or signalling to the neighbouring cells, which
induce their antiviral state by the stimulation of tran-
scription from the ISRE promoter-containing genes [28].
The viral NS1 of influenza A viruses is known to be an
important regulator of innate immunity on many levels
[13-16]. The NS1 inhibits host immune responses
through two functional domains: an N-terminal RNA
Figure 2 IFN-b release in the supernatant and expression of
IFN-b m-RNA in human A549 epithelial cells in response to
poly I:C challenge at the presence of different NS1 proteins. (A)
The concentration of IFN-b in A549 cell supernatants was assayed.
Cell were transfected with plasmids containing either the NS gene
of “mink/84” or “chicken/49” virus or was mock treated, 24 hours
later cells were stimulated with 5 μg/ml of poly I:C. The cell
supernatants were collected at 0, 2, 4, 8, 16, 24 and 48 hours post-
poly I:C stimulations. Expression of IFN-b m-RNA in A549 cells in
response to poly I:C challenge at the presence of different NS1
proteins. A549 cells were transfected with (B) empty pCDNA-3
vector, (C) pNS-mink/84 and (D) pNS-chicken/49 respectively, 24 h
later cell were treated with 5 μg/ml poly (I:C) for indicated time.
Data are expressed as the mean value for the three independent
experiments performed in duplicate.
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The effector domain interacts with proteins involved in
the 3’-end cellular mRNA processing, inhibits mRNA
export and pre-mRNA splicing of host cell transcripts
and interacts with components of the nuclear pore com-
plex as well as the mRNA export machinery [29-34].
The N-terminal RNA binding domain binds to both sin-
gle- and double-stranded RNA that might inhibit the
activation and/or signalling of antiviral proteins, such as
RIG-I, PKR, OAS/RNase L, activators of mitogen-
activated protein kinase and transcription factors involved
in type I IFN and inflammatory cytokine signalling
[20,22,23,35-37].
Our previous study indicated that the NS1 protein is a
potential key factor for the different pathogenicity levels
of the H10 avian influenza viruses in mink (Mustela
vison) [27]. In this study, we applied an expression plas-
mid system carrying the ORF of NS1 of two avian influ-
enza viruses, showing the difference in pathogenicity in
mink [38]. Furthermore, these viruses represent different
NS alleles, one from A ("mink/84”) and the other one
from B ("chicken/49”). A comparison of the predicted
amino acid sequences of the two NS1 proteins showed
71 amino acid differences (Figure 3). However, the two
NS1 proteins were found to be very similar regarding
the previously identified important amino acid residues
for the function of NS1 protein in the infected cells
[23,29,30,34,39,40].
N o t a b l y ,t h eo n l yd i f f e r e n c ew a sf o u n di nt h es i t e
important for the NS1 protein’s interaction with the 30
kDa subunit of cleavage and polyadenylation specificity
factor (CPSF30) [27]. The NS1 protein interaction with
the CPSF30 inhibits 3’-end processing of cellular pre-
mRNA [29,30,34]. This function is mediated by two dis-
tinct domains: one around residue 186 [30] and the
other around residues 103 and 106 [41]. The NS1 pro-
tein of “mink/84” possessed the amino acid Glu186,
Phe103 and Met106, whereas the NS1 protein of
“chicken/49” possessed Tyr 103. A previous study [41]
showed that mutations at the NS1 protein CPSF30
interaction sites dramatically changed the effect of the
NS1 to control host gene expression.
Both “mink/84” and “chicken/49” NS1s had a negative
effect on the activation of the ISRE promoter, as shown
by the luciferase activity. But the reduction was much
stronger in cells transfected with the “mink/84” NS1
plasmid with an average of 85.3% decrease in A549 cells
(Figure 1A), whereas pNS-chicken/49 on average pro-
duced a 20.8% decrease in A549 cells. As this final pro-
duct is dependent on both the induction of IFN and
luciferase from the IFN receptor, the exact mechanism
by which this interference is mediated through can be
either by inhibiting IFN induction signals via RIG-I,
MDA-5 or TRL-3, the processing of IFN mRNA, or the
downstream effects via IFN receptor signalling or luci-
ferase mRNA processing.
Several studies have indicated that the blocking of
virus-induced IFN-b promoter activation is mediated by
the N-terminal RNA binding domain of the NS1 protein
[42-44]. The 71 amino acid differences between the two
NS1 proteins will most likely result in differences on the
three-dimensional structure of the NS1 protein that
could affect the function of NS1 in the suppression of
IFN-b promoter activation.
Since the induction of the IFN-b promoter is asso-
ciated with the production of IFN-b, we next investi-
gated the level of endogenous IFN-b mRNA and the
amount of IFN-b secreted in the cell supernatant. It has
been observed that the NS1 protein of “mink/84” but
not “chicken/49” strongly suppressed the expression of
the IFN-b gene and secretion of IFN-b in the cell cul-
ture supernatant. In the time course study using A549
cells stimulated with poly I:C, IFN-b production dis-
played three distinct phases. After an initial rapid
increase it reached a peak and then declined to lower
levels. The production of IFN-b by poly I:C stimulation
in A549 cells displayed a 2- to 4-hours lag followed by a
steady increase in the accumulation of secreted IFN-b in
the cell culture media. Maximal yields were observed at
16 to 24 h post poly I:C stimulation (Figure 2A).
Similar observations were made when mRNA levels
were measured. The expression during poly I:C stimula-
tion revealed an early up regulation of IFN-b transcripts
starting at or before 2 h with a peak at 18-24 h after
Figure 3 The predicted NS1 amino acid sequence alignments for the “mink/84” and “chicken/49” viruses.T h eb o x e si n d i c a t e st h e
previously identified important amino acid residues for the function of NS1 protein in the infected cells.
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observed an up regulation of IFN-b mRNA transcripts
in A549 cells expressing the NS1 protein of “mink/84”.
Thereafter, the IFN-b gene transcription was strongly
suppressed, whereas a high level of the IFN-b mRNA
expression continued in A549 cells expressing NS1 pro-
tein of “chicken/49” (Figure 2B,C&2D).
Future experiments are required to investigate the
exact molecular mechanism behind this observation.
This may require the use of animal experiments and
also includes tools like reverse genetics, genomics and
proteomic tools that allows the analysis of many para-
meters involved in the complex interplay between the
NS1 and the host innate immune machinery.
Conclusions
All these observations indicate that different non-
structural protein 1 (NS1) of influenza viruses, one
from allele A and another from allele B, show different
abilities to suppress the induction of IFN mRNA; how-
ever, the exact mechanism is unknown. The results
also demonstrate that the production of an important
cytokine, IFN-b is affected by the function of NS1 pro-
tein from different genetic gene pools.
It is possible that NS1 interacts with one of the inducing
pathways, or both, or that the mRNA processing is
blocked. The latter can be studied by investigating another
inducible gene other than an IFN-dependent one.
Methods
After establishing an assay protocol for different part of
our study, both NS1 construct were tested in duplicate
at three independent experiments (each experiment was
set up separately and carried out on different days).
Construction of expression plasmids
The NS1 open reading frames (ORF) of influenza A
virus strains A/mink/Sweden/3900/84 ("mink/84”)a n d
A/chicken/Germany/N/49 ("chicken/49”) were amplified
using the primers NS1Kpn 5’ (5’-ATTCGGTACCAG-
CAAAAGCAGGGTGACAAAG-3’)a n dN S 1 X h o I3 ’ (5’-
TACCCTCGATAGAAACAAGGGTGTTTTTTAT-3’).
Twenty-five microliter PCR-mix contained 1xPlatinum
Taq buffer (Invitrogen), 200 μMd N T P ,2 . 5m MM g C l 2,
(Invitrogen) and 3 μl cDNA. Reactions were placed in a
thermal cycler at 95°C for 2 min, then cycled 35 times
between 95°C 20 sec, annealing at 58°C for 60 sec and
elongation at 72°C for 90 sec and were finally kept at 8°
C until later use.
The 690 bp PCR products were digested with Kpn and
XhoI and cloned between the Kpn and XhoI sites of the
mammalian expression vector pcDNA3.1 (Invitrogen,
Carlsbad, CA, USA), creating pNS-mink/84 and pNS-
chicken/49 plasmid respectively. The integrity of the
plasmids was confirmed by sequencing.
Cell culture and transfection experiments
A549 cells, a type II alveolar epithelial cell line from
human adenocarcinoma, (ATCC, CCL 185) were cul-
tured in Dulbecco’s modified Eagle medium (DMEM)
and supplemented with 10% FCS in a humidified atmo-
sphere of 5% CO2 at 37°C.
Transcriptional activity was assayed in the A549 cells.
Cells were co-transfected with plasmids containing either
the NS gene of “mink/84” or “chicken/49” together with
reporter plasmids driving expression of Firefly luciferase
(pISRE-TA-Luc) (Invitrogen) under the control of the
IFN-stimulated response element (ISRE). The pRen-Luc
plasmid containing the Renilla luciferase gene (Invitro-
gen) was used as internal control. The activity of the
reporter gene were standardised by the Renilla luciferase
activity. The inhibitory effect in cells expressing the var-
ious NS1s was expressed in folds of luciferase activity.
The transfection of the plasmids was conducted with
FuGENE 6 reagent (Roche Molecular Biochemicals,
Indianapolis, IN) in six-well plates according to the
manufacturer’s instructions. Initial experiments were
conducted to optimise the efficiency of the transfection
protocol. The day before transfection, cells were col-
lected and seeded into six-well plates at 1 × 10
5 cells
per well to achieve 70-80% confluence on the day of
transfection. Each transfection group consisted of six
w e l l si nw h i c ht h r e ew e r ep o l yI : Cs t i m u l a t e da n dt h r e e
mock treated. Stimulation of the cells with the poly I:C
was performed 24 hours after transfection of the
pcDNA3.1/NS1 plasmid through the addition of 5 μg/
ml poly I:C mixed in 100 μl DMEM without serum.
Twenty-four hours later, the cells were harvested
according to the protocol for the luciferase assay kit
(Stratagene, Heidelberg, Germany), using 300 μll y s i s
buffer for each well. Samples were kept on ice and cen-
trifuged for 2 min at 14,000 × g to remove cell debris
before measurement of the luciferase activity. Luciferase
activities were measured using 20 μl of each sample
according to the manufacturer’s protocol.
Western blot analysis
All the transfections for western blot analysis were
performed following the same protocol as described
above. Briefly, cells were washed and lysed at 0, 2, 4,
8, 16 and 24 hours post transfection using Bio-Plex
cells lysis kit (Bio-Rad Laboratories, Hercules, CA)
according to the manufacturer’s instructions. After
incubation for 20 min at 4°C and three times thawing-
freezing steps at -70°C, the lysates were centrifuged at
4500 rpm for 20 min. Concentration and quality of
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(Nanodrop Technologies, Wilmington, DE.) and by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
followed by Coomassie blue staining. A total of 50 μg
of the cell lysate was separated bySDS-PAGE in Ready
Gel J 7.5% (Bio-Rad) and then electronically trans-
ferred onto polyvinylidene difluoride (PVDF) mem-
brane (GE Healthcare, Uppsala, Sweden). The
membranes were incubated in blocking buffer (PBS,
2% (wt/vol) bovine serum albumin) at room tempera-
ture for one hour on slow agitation, the NS1and b-
actin proteins were detected using anti-NS1 polyclo-
nal, the NS1 antibodies was raised in goat against a
peptide mapping near the C-terminus of influenza A
NS1 (sc-17596, Santa Cruz Biothechnology, INC) and
anti b-actin (Sigma-Aldrich, Stockholm, Sweden) , fol-
lowed by incubation with primary antibodies diluted
in TBS-2% BSA at 4°C overnight. After intensive
washing with TBS (PBS, 0.2% Tween 20) membranes
were incubated with horseradish peroxidase (HRP)-
conjugated anti-goat secondary antibodies for the NS1
and anti-mouse secondary antibodies for the b-actin
detection for two hours at room temperature on con-
tinuous agitation. The blots were developed by an
ECL advance kit from GE Healthcare and visualized in
ChemDoc XRS system from Bio-Rad with Quantity
One® software.
Human IFN-b ELISA
The concentration of IFN-b in stimulated A549 cell
supernatants was determined using a commercially
available VeriKine™ human IFN-beta sandwich enzyme-
linked immunosorbent assay (ELISA) kit (PBL interferon
source, Piscataway, NJ, USA) according to the manufac-
turer’s instructions. The cell supernatants were collected
at 0, 2, 4, 8, 16, 24 and 48 hours post-poly I:C stimula-
tions. Briefly, microtiter strips were incubated with 100
μl of IFN standards, blanks and samples. After one hour
of incubation, the strips were washed and detection
antibodies were added. After incubation and an addi-
tional washing step, streptavidin conjugated to horserad-
ish peroxidase (HRP) was added, and the strips were
incubated at room temperature for 1 hour. The strips
were again washed before the addition of the tetra-
methyl benzidine (TMB) substrate solution, after which
the strips were incubated for 15 min at room tempera-
ture in the dark. The reaction was terminated by the
addition of stop solution, and the optical density of the
wells was read at 450 nm using a microplate reader
Multiscan EX (Thermo scientific, MA, USA). Values for
the samples were compared to those for the standard
curve and the amount of IFN-b was estimated from the
standard curve.
Analysis of IFN-b mRNA by RT-PCR
RT-PCR was used to study the level of IFN-b mRNA
expression in Poly I:C-stimulated A549 cells. The house-
keeping gene b-actin was used as a control. RT-PCR
was performed using the following primer pairs specific
to human IFN-b and b-actin mRNA: IFN-b forward
5’ GGCCATGACCAACAAGTGTCTCCTCC 3’ and
reverse 5’ ACAGGTTACCTCCGAAACTGAGCGC 3’,
resulting a product of 550 bp; and b-actin forward
5’ TGGGTCAGAAGGACTCCTATG 3’ and reverse
5’ AGAAGAGCTATGAGCTGCCTG 3’.T w e n t y - f i v e
microliter PCR-mix contained 1xPlatinum Taq buffer
(Invitrogen), 200 μMd N T P ,2 . 5m MM g C l 2,( I n v i t r o -
gen) and 3 μl cDNA. Reactions were placed in a thermal
cycler at 95°C for 2 min, then cycled 35 times between
95°C 20 sec, annealing at 63°C for 60 sec and elongation
at 72°C for 90 sec and were finally kept at 8°C until
later use.
A549 cells were seeded in six-well plates and trans-
fected with either pNS-mink/84, pNS-chicken/49 or
empty pcDNA 3.1 vector as described above. Cells were
stimulated with 5 μg/ml poly I:C mixed in 100 μl
DMEM without serum. Cells were harvested and RNA
was extracted for RT-PCR assays at 0, 4, 8, 16 and 24
hours post-stimulation.
RNA was isolated using TRIzol Reagent (Invitrogen)
according to the manufacturer’sp r o t o c o l .R N Aw a s
DNAse-treated and quantified and purity measured at
OD260/280 using a Nanodrop ND1000 (Nanodrop Tec.,
Wilmington, DA, USA). All RNA samples had an
OD260/280 ratio in water between 1.9 and 2.1. 2 μgR N A
was used to make cDNA templates using Superscript II
(Invitrogen) according to the manufacturer’s instructions
and oligo-dT primers (Invitrogen).
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